期刊文献+

洛伐他汀影响人高转移卵巢癌细胞系HO-8910PM转移相关能力的研究 被引量:2

Effect of lovastatin on metastasis-associated ability of highly metastatic ovarian carcinoma cell line HO-8910PM
下载PDF
导出
摘要 目的研究洛伐他汀对人高转移卵巢癌细胞系HO-8910PM转移相关能力的影响。方法分别运用MTT法、Transwell小室法、细胞粘附人工重组基底膜实验检测洛伐他汀对HO-8910PM细胞的细胞毒作用,对细胞的侵袭能力和趋化运动及对细胞粘附能力的影响。结果洛伐他汀作用HO-8910PM细胞6h后能抑制其体外侵袭、趋化运动和粘附能力,其中8μmol/L抑制率分别为(79.18±0.21)%、(59.40±0.80)%和(14.08±1.28)%。结论洛伐他汀能有效地抑制人高转移卵巢癌细胞系HO-8910PM的侵袭、趋化运动和粘附能力,是潜在的抗肿瘤转移药物。 Objective To investigate the effect of lovastatin on the metastasis-associated ability of highly metastatic ovarian carcinoma cell line HO-8910PM. Methods After pretreatment with lovastatin, cytotoxicity, invasion and migration capacity, and adhesion potential of HO-8910PM cells were determined by MTT assay, Transwell chamber assay and cell matrigel adhesion assay, respectively. Results Lovastatin pretreatment inhibited the invasion, migration and adhesion capacity of HO-8910PM cells after 6 hours, and its inhibitory rates at dose of 8 μmol/L, were (79.18 ± 0.21) %, (59.40 ± 0.80) % and ( 14.08 ± 1.28) %, respectively. Conclusion Lovastatin may be a potential antitumor drug by inhibiting the invasion, migration and adhesion capacity of HO-8910PM cells.
出处 《广东医学院学报》 2008年第4期373-376,共4页 Journal of Guangdong Medical College
基金 湛江市科技攻关项目(No.2007C04002)
关键词 洛伐他汀 侵袭 运动 转移 卵巢癌 lovastatin invasion migration metastasis ovarian carcinoma
  • 相关文献

参考文献9

  • 1Feng C, Han A, Ye C, et aI. The HMG-CoA reductase pathway, statins and anglo-prevention [J]. Semin Ophthalmol, 2006, 21(1) :29-35.
  • 2Wang I K, Lin-Shiau S Y, Lin J K. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by Iovastatin through inhibition of ras isoprenylation [ J ]. Oncology, 2000, 59(3):245-254.
  • 3Van D E, Donk N W, Lokhorst H M, et aI. Geranylgeranylated proteins are involved in the regulation of myeloma ceil growth[J]. Clin Cancer Res, 2005,11 (2 Pt 1 ):429-439.
  • 4Cafforio P, Dammacco F, Gemone A, et al. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells [ J ]. Carcinogenesis, 2005, 26 ( 5 ) : 883- 891.
  • 5Farina H G, Bublik D R, Alonso D F, et al. Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells [ J ]. Clin Exp Metastasis, 2002,19(6) :551-559.
  • 6马卫列,丁航,符伟玉,周克元.三羟异黄酮对高转移卵巢癌细胞株HO-8910PM的侵袭、转移及MTA1、nm23H_1基因表达的影响[J].广东医学院学报,2006,24(3):230-232. 被引量:3
  • 7Erickson J R, Hasegawa Y, Fang X, et al. Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management [J]. Prostaglandins, 2001, 64 (1/4) : 63- 81.
  • 8Liotta L A, Stetler-Stevenson W G. Tumor invasion and metastasis: an imbalance of positive and negative regulation [J]. Cancer Res, 1991, 51(18 SuppI):5054s-5059s.
  • 9Appels N M, Beijnen J H, SchelIens J H. Development of famesyl transferase inhibitors: a review[ J ]. Oncologist, 2005, 10(8) :565-578.

二级参考文献13

  • 1POLKOWSKI K,MAZUREK A P.Biological properties of genistein.A review of in vitro and in vivo data[J].Acta Pol Pharm,2000,57(2):135-155.
  • 2RAKESH K,WANG R A,BAGHERI-YARMAND R.Emerging Roles of MTA Family members in human cancers[J].Semi Oncol,2003,30(5):30-37.
  • 3TOH Y,OHGA T,KNDO K,et al.Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas[J].Int J Cancer,2004,110(3):362-367.
  • 4STEEG PS,BEVILACQUA G,KOPPER L,et al.Enidence for a novel gene associated with low tumor metastatic protential[J].J Natl Cancer Inst,1988,80(3):200-203.
  • 5STAHL J A,LEONE A,ROSENGARD AM,et al.Identification of a second human nm23 gene,nm23H2[J].Cancer Res,1991,51(1):445-447.
  • 6TOH Y,OHGA T,ENDO K,et al.Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas[J].Int J Cancer,2004,110(3):362-367.
  • 7IGUCHI H,IMURA G,TOH Y,et al.Expression of MTA1,a metas tasis-associated gene with histone deacetylase activity in pancreat iccancer[J].Int J Oncol,2000,6(6):1211-1214.
  • 8MASALKI T,TAKAMORI A,YASUNORI M,et al.Expression of nm23H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival[J].BMC Cancer,2001,1(1):3-6.
  • 9刘红岩,韩锐.金荞麦提取物抑制肿瘤细胞侵袭、转移和HT-1080细胞产生Ⅳ型胶原酶的研究[J].中国药理学通报,1998,14(1):36-39. 被引量:53
  • 10许沈华,钱丽娟,牟瀚舟,倪型灏,朱赤红,张谷,戴惠芳,高永良.高转移人卵巢癌细胞系HO-8910PM的建立及其生物学特性[J].中华病理学杂志,1998,27(6):451-452. 被引量:34

共引文献2

同被引文献9

  • 1Feng C, Han A, Ye C, et al. The HMG-CoA reductase pathway, statins and anglo- prevention [ J ]. Semin Ophthalmol, 2006, 21(1) :29-35.
  • 2Cafforio P, Dammacco F, Gemone A, et al. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells [J]. Carcinogenesis, 2005, 26 (5) : 883- 891.
  • 3Waxman D J, Schwartz P S. Harmes.sing apoptosis for improved anticancer gene therapy [J]. Cancer Res, 2003, 63 (24) :8563-8572.
  • 4Dimitroulakos J, Nohynek D, Backway K L, et al. Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach [J]. Blood, 1999, 93(4) : 1308- 1318.
  • 5Farina H G, Bublik D R, Alonso D F, et al. Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells[J]. Clin Exp Metastasis, 2002, 19(6) : 551-559.
  • 6Wang I K, Lin-Shiau S Y, Lin J K. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by Simvastatin through inhibition of ras isoprenylation [J]. Oncology, 2000, 59(3):245-254.
  • 7van de Donk N W, Lokhorst H M, Nijhuis E H, et al. Geranylgeranylated proteins are involved in the regulation of myeloma cell growth[J]. Clin Cancer Res, 2005,11(2 Pt 1) : 429-439.
  • 8张建和,符伟玉,覃燕梅,梁念慈.洛伐他汀对高转移卵巢癌细胞HO-8910PM细胞周期和增殖的影响[J].实用癌症杂志,2008,23(3):227-229. 被引量:2
  • 9熊蕴珠,黄建鸣,张国楠.卵巢癌相关细胞因子的过表达及其在肿瘤微环境中作用的研究进展[J].肿瘤预防与治疗,2014,27(1):39-42. 被引量:5

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部